![](/img/cover-not-exists.png)
Safety and timing of resuming dabigatran after major gastrointestinal bleeding reversed by idarucizumab
Riario Sforza, Gian Galeazzo, Gentile, Francesco, Stock, Fabio, Caggiano, Francesco, Chiocca, Enrica, Incorvaia, CristoforoVolume:
6
Language:
english
Journal:
SAGE Open Medical Case Reports
DOI:
10.1177/2050313X17753336
Date:
January, 2018
File:
PDF, 111 KB
english, 2018